HLBBIOSTEPHLBBIOSTEPHLBBIOSTEP

HLBBIOSTEP

No trades
See on Supercharts

278650 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

HLB bioStep Co., Ltd. engages in the provision of clinical research services. It operates through the following business divisions: Non-Clinical Contract Research Organizations (CRO), Bioinfrastructure, and Pet Medical. The Non-Clinical CRO business division focuses on pharmacology and toxicity evaluation. The Bioinfrastructure business division is invloved in the design, construction, and maintenance of animal testing facilities, as well as supply of equipment and materials. The Pet Medical business division distributes and sells veterinary medicines. The company was founded on April 19, 2012 and is headquartered in Inchon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
278650 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company